본문 바로가기

전체 글

 (819)
Recent pharma happening for AbCellera, Gilead and GlaxoSmithKline AbCellera grabs USD 105 Million for series B funding round. AbCellera has grabbed a significant USD 105 million series B funding round. The funding will help its antibody work and quest for new potential meds against COVID-19. Gilead inks USD 2 Billion deal with Arcus. Gilead Sciences is paying USD 175 million upfront with a USD 200 million equity investment weighted in. Arcus Biosciences could ..
Immune Thrombocytopenia Market The market size of Immune Thrombocytopenia in 7MM was USD 2527.72 Million in 2017. The total prevalent population of Immune Thrombocytopenia in the 7MM is estimated to be approximately 184,676 in 2020. The key players in the Immune Thrombocytopenia market include Octapharma USA, Amgen, CSL Behring, Dova Pharmaceuticals, Rigel Pharmaceuticals, Novartis, Bio Products Laboratory, Takeda, AstraZenec..
Hunter Syndrome Market The Hunter Syndrome Market is expected to increase with a CAGR of 7.5% in 7MM during the study period (2017-2030). The total diagnosed prevalent population of Hunter Syndrome in 7MM was 1,166 in 2017. The key players in Hunter Syndrome Market include Takeda, JCR Pharmaceuticals, GC Pharma, Regenxbio, Denali Therapeutics, Sangamo Therapeutics, ArmaGen and others. For more details visit: https://w..
Precision Medicine The concept of Precision medicine has been part of healthcare for a very long time, but the rapid progression observed in recent years is quite significant. Precision medicine can be helpful in providing treatment to a wide variety of diseases such as melanomas, leukaemias, lung and breast cancer. Apart from the cancerous diseases, precision medicine can also play an important role in prediction..
Adrenoleukodystrophy Market As per DelveInsight, in 2017, the total prevalent population of Adrenoleukodystrophy in the 7MM was 55,242. A higher percentage of diagnosed prevalence was observed for females, in comparison to males, in all the 7MM countries during the study period (2017–2030). The market size for Adrenoleukodystrophy in the United States was USD 523.26 million in 2017. The market of Adrenoleukodystrophy is ex..
Immune Thrombocytopenia The Immune Thrombocytopenia market size in the 7MM was approximately USD 2,527.72 million in 2017. The United States accounts for the largest ITP market size. Prospective trials, by several pharma companies including Octapharma USA, Amgen, CSL Behring, Dova Pharmaceuticals, Rigel Pharmaceuticals, Zenyaku Kogyo/Biogen Idec, Novartis, Takeda, AstraZeneca, Biotest, GC Pharma, SK Plasma, Argenx, Kez..
Hunter Syndrome Market Occurring in approximately 1 in 100,000 to 1 in 170,000 male births, Hunter Syndrome, is an X-linked disorder, of carbohydrate metabolism that occurs almost exclusively in males, with females as the carriers of the diseases. The HunterSyndrome Market is expected to experience a positive push in the coming years with a CAGR of 7.5% for 7MM. The key players in the Hunter Syndrome Market include JC..
Recent Pharma Happenings CanSino Biologics and Precision NanoSystems Announce Collaboration The partners will work on an mRNA nanoparticle vaccine for COVID-19, with Precision NanoSystems designing the vaccine and CanSino undergoing preclinical and clinical development, regulatory activities and commercialization. Atea has raised USD 215 Million to support mid-phase COVID-19 antiviral trials. The series D establish Atea..

티스토리툴바